Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Compass Therapeutics (CMPX) Net Margin (2024)

Historic Net Margin for Compass Therapeutics (CMPX) over the last 1 years, with Q2 2024 value amounting to 1538.35%.

  • Compass Therapeutics' Net Margin changed N/A to 1538.35% in Q2 2024 from the same period last year, while for Mar 2025 it was 6884.94%, marking a year-over-year change of. This contributed to the annual value of 6661.76% for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q2 2024, Compass Therapeutics' Net Margin is 1538.35%.
  • In the past 5 years, Compass Therapeutics' Net Margin registered a high of 1538.35% during Q2 2024, and its lowest value of 1538.35% during Q2 2024.